Fluocinonide

"Vanos" redirects here. It is not to be confused with VANOS or VanossGaming.
Fluocinonide
Clinical data
Trade names Lidex
AHFS/Drugs.com Micromedex Detailed Consumer Information
MedlinePlus a601054
Pregnancy
category
  • C
Routes of
administration
topical
ATC code C05AA11 (WHO) D07AC08 (WHO)
Legal status
Legal status
  • AU: S4 (Prescription only)
  • UK: POM (Prescription only)
  • US: ℞-only
Pharmacokinetic data
Metabolism hepatic
Identifiers
CAS Number 356-12-7 YesY
PubChem (CID) 9642
IUPHAR/BPS 7078
DrugBank DB01047 YesY
ChemSpider 9265 YesY
UNII 2W4A77YPAN YesY
KEGG D00325 YesY
ChEMBL CHEMBL1501 YesY
Chemical and physical data
Formula C26H32F2O7
Molar mass 494.525 g/mol
3D model (Jmol) Interactive image
  (verify)

Fluocinonide (Fluonex, Lidex, Lidex-E, Lonide, Lyderm, and Vanos)[1] is a potent glucocorticoid used topically as an anti-inflammatory agent for the treatment of skin disorders such as eczema and seborrhoeic dermatitis. It relieves itching, redness, dryness, crusting, scaling, inflammation, and discomfort.

The usual prescription concentration is 0.05% as a topical cream, ointment, solution, or gel. The application area should normally not be covered after application. In certain cases, the physician may recommend the use of an occlusive dressing after application to increase the rate and depth of absorption. The frequency of application depends on the condition being treated and the area affected, but most often it should be applied 2 to 4 times a day.[2]

Fluocinonide ranks as a "high-potency" (second-highest rank) topical corticosteroid. Minimal amounts should be used for a minimal length of time to avoid the occurrence of adverse effects..

Fluocinonide should not be used if infection is present. It should not be applied to the eyes or to sensitive areas such as the genitals or anus.

A common potential adverse effect is skin atrophy (thinning of the skin). Systemic absorption of topical corticosteroids can produce reversible hypothalamic-pituitary-adrenal axis (HPA) suppression, manifestations of Cushing's syndrome, hyperglycemia, and glucosuria in some patients.

Fluocinonide should be used with caution when treating children, pregnant women, nursing mothers, and anyone using the medication for longer than two weeks.

Fluocinonide is used in veterinary medicine. It is a treatment for allergies in dogs.[3] Natural systemic cortisol concentrations can be suppressed for weeks after one week of topical exposure.[4]

See also

References

  1. MedlinePlus Drug Information: Fluocinonide Topical
  2. "Fluocinonide Topical". MedlinePlus. US National Library of Medicine, NIH. Retrieved 6 March 2014.
  3. Dog Allergies www.squidoo.com/dogallergy
  4. Zenoble RD, Kemppainen RJ . (1987-09-15). "Adrenocortical suppression by topically applied corticosteroids in healthy dogs". J Am Vet Med Assoc. 191 (6): 685–8. PMID 2824410.
This article is issued from Wikipedia - version of the 7/31/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.